(STL.News) The U.S. Food and Drug Administration on Monday (November 9) authorized emergency use of Eli Lilly and Co’s experimental COVID-19 antibody treatment for non-hospitalized patients older than 65 or who have certain chronic medical conditions.
YouTube video is provided courtesy of WION News